173 related articles for article (PubMed ID: 36249772)
21. Adverse drug reactions (ADRS) reporting: awareness and reasons of under-reporting among health care professionals, a challenge for pharmacists.
Shamim S; Sharib SM; Malhi SM; Muntaha SU; Raza H; Ata S; Farooq AS; Hussain M
Springerplus; 2016; 5(1):1778. PubMed ID: 27795920
[TBL] [Abstract][Full Text] [Related]
22. Influence of pharmacists' attitudes on adverse drug reaction reporting : a case-control study in Portugal.
Herdeiro MT; Figueiras A; Polónia J; Gestal-Otero JJ
Drug Saf; 2006; 29(4):331-40. PubMed ID: 16569082
[TBL] [Abstract][Full Text] [Related]
23. An exploratory study of knowledge, attitudes, practice and barriers towards adverse drug reaction reporting among healthcare professionals in Malta.
Curtolo E; Micallef B; Szijj JV; Serracino-Inglott A; Borg JJ
Int J Risk Saf Med; 2024 May; ():. PubMed ID: 38820023
[TBL] [Abstract][Full Text] [Related]
24. Medication safety knowledge, attitude, and practice among hospital pharmacists in tertiary care hospitals in Saudi Arabia: a multi-center study.
Al-Mutairi A; AlFayyad I; Altannir Y; Al-Tannir M
Arch Public Health; 2021 Jul; 79(1):130. PubMed ID: 34253257
[TBL] [Abstract][Full Text] [Related]
25. A national survey of knowledge, attitude, practice, and barriers towards pharmacovigilance and adverse drug reaction reporting among hospital pharmacy practitioners in the United Arab Emirates.
Shanableh S; Zainal H; Alomar M; Palaian S
J Pharm Policy Pract; 2023 Jul; 16(1):92. PubMed ID: 37464445
[TBL] [Abstract][Full Text] [Related]
26. Pharmacists' attitudes toward adverse drug reaction reporting in Hong Kong.
Lee KK; Chan TY; Raymond K; Critchley JA
Ann Pharmacother; 1994 Dec; 28(12):1400-3. PubMed ID: 7696734
[TBL] [Abstract][Full Text] [Related]
27. Knowledge, Attitude, and Barriers Toward ADRs Reporting Among Health-Care Professionals at Tertiary Care Health Settings in Peshawar, Pakistan: A Web Based Study.
Ali I; Ahmad W; Ullah AR; Khan F; Ijaz M; Khan S; Khan TM
Hosp Pharm; 2021 Aug; 56(4):384-391. PubMed ID: 34381279
[No Abstract] [Full Text] [Related]
28. Community pharmacists' challenges regarding adverse drug reaction reporting: a cross-sectional study.
Paut Kusturica M; Tomas A; Rašković A; Gigov S; Crnobrnja V; Jevtić M; Stilinović N
Curr Med Res Opin; 2022 Jul; 38(7):1229-1236. PubMed ID: 35470747
[TBL] [Abstract][Full Text] [Related]
29. Linking Activity Theory Within User-Centered Design: Novel Framework to Inform Design and Evaluation of Adverse Drug Reaction Reporting Systems in Pharmacy.
Fossouo Tagne J; Yakob RA; Mcdonald R; Wickramasinghe N
JMIR Hum Factors; 2023 Feb; 10():e43529. PubMed ID: 36826985
[TBL] [Abstract][Full Text] [Related]
30. A National Survey of Community Pharmacists' Viewpoints About Pharmacovigilance and Adverse Drug Reaction Reporting in Saudi Arabia.
Alsheikh MY; Alasmari MM
Front Pharmacol; 2022; 13():819551. PubMed ID: 35721182
[TBL] [Abstract][Full Text] [Related]
31. Hospital pharmacists' knowledge and opinions regarding adverse drug reaction reporting in Northern China.
Su C; Ji H; Su Y
Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):217-22. PubMed ID: 20033911
[TBL] [Abstract][Full Text] [Related]
32. Severity and Management of Adverse Drug Reactions Reported by Patients and Healthcare Professionals: A Cross-Sectional Survey.
Srisuriyachanchai W; Cox AR; Kampichit S; Jarernsiripornkul N
Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36834422
[TBL] [Abstract][Full Text] [Related]
33. Predictive Factors of Spontaneous Reporting of Adverse Drug Reactions among Community Pharmacists.
Yu YM; Lee E; Koo BS; Jeong KH; Choi KH; Kang LK; Lee MS; Choi KH; Oh JM; Shin WG
PLoS One; 2016; 11(5):e0155517. PubMed ID: 27192159
[TBL] [Abstract][Full Text] [Related]
34. Community pharmacists' views on adverse drug reactions reporting in Malaysia: a pilot study.
Ting KN; Stratton-Powell DM; Anderson C
Pharm World Sci; 2010 Jun; 32(3):339-42. PubMed ID: 20336371
[TBL] [Abstract][Full Text] [Related]
35. Do Health Professionals have Positive Perception Towards Consumer Reporting of Adverse Drug Reactions?
Alshakka MA; Ibrahim MI; Hassali MA
J Clin Diagn Res; 2013 Oct; 7(10):2181-5. PubMed ID: 24298470
[TBL] [Abstract][Full Text] [Related]
36. Factors that facilitate reporting of adverse drug reactions by pharmacists in Saudi Arabia.
Aldryhim AY; Alomair A; Alqhtani M; Mahmoud MA; Alshammari TM; Pont LG; Kamal KM; Aljadhey H; Mekonnen AB; Alwhaibi M; Balkhi B; Alhawassi TM
Expert Opin Drug Saf; 2019 Aug; 18(8):745-752. PubMed ID: 31232612
[No Abstract] [Full Text] [Related]
37. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
[TBL] [Abstract][Full Text] [Related]
38. Characteristics and quality of adverse drug reaction reports by pharmacists in Norway.
Gedde-Dahl A; Harg P; Stenberg-Nilsen H; Buajordet M; Granas AG; Horn AM
Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):999-1005. PubMed ID: 17457794
[TBL] [Abstract][Full Text] [Related]
39. Knowledge, attitudes & practices of healthcare professionals in hospitals towards the reporting of adverse drug reactions in Saudi Arabia: A multi-centre cross sectional study.
AlShammari TM; Almoslem MJ
Saudi Pharm J; 2018 Nov; 26(7):925-931. PubMed ID: 30416347
[TBL] [Abstract][Full Text] [Related]
40. Views of British community pharmacists on direct patient reporting of adverse drug reactions (ADRs).
Krska J
Pharmacoepidemiol Drug Saf; 2013 Oct; 22(10):1130-3. PubMed ID: 22729956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
